Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 989

Bacillus subtilis expressing a modified gene encoding a variant of the wild-type subtilisin from B. clausii

Intended Use: Intended for use as an enzyme to hydrolyze proteins from microbial, plant, milk, and seafood sources at up to 569 mg Total Organic Solids (TOS)/kg raw material.
Basis: Scientific procedures
Notifier: Danisco US Inc. (operating as DuPont Nutrition and Biosciences)
Notifier Address: 925 Page Mill Road
Palo Alto, CA 94304
GRAS Notice (releasable information): GRN 989 with amendments (in PDF) (6.6 MB)
Date of closure: Jun 30, 2022
FDA's Letter: FDA has no questions (in PDF) (144 kB)
-
-